Landos Biopharma, Inc. (LABP) Financials
LABP Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-09-30 | 43.2 million | 5.6 million |
| 2023-06-30 | 46.3 million | 3.0 million |
| 2023-03-31 | 51.2 million | 4.2 million |
| 2022-12-31 | 45.3 million | 6.1 million |
LABP Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-09-30 | -2.2 million | 248000 |
| 2023-06-30 | -5.1 million | 254000 |
| 2023-03-31 | -8.2 million | 224000 |
| 2022-12-31 | -3.7 million | 196000 |
LABP Net Income
No data available :(
LABP Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-09-30 | 42.5 million | - | - |
| 2023-06-30 | 44.7 million | - | - |
| 2023-03-31 | 50.0 million | - | - |
| 2022-12-31 | 44.4 million | - | - |
LABP Shares Outstanding
LABP Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-09-30 | - | 3.1 million | 2.1 million | - |
| 2023-06-30 | - | 2.5 million | 2.0 million | - |
| 2023-03-31 | - | 3.3 million | 3.2 million | - |
| 2022-12-31 | 7000 | 3.4 million | 3.1 million | - |
LABP Cost of Revenue
No data available :(
LABP
Price: $22.24
52 week price:
Earnings Per Share: -3.50 USD
P/E Ratio: -1.37
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 125700
Market Capitalization: 69.4 million